The ecosystem of companies competing to develop therapies for weight loss is growing every day, and there's more than one ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Within that, the five-year trial, conducted in collaboration with Health Innovation Manchester, will also explore how weight-loss drugs impact ... Radio 4’s Today program on Tuesday.

As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a ...

Even though there is no official Ozempic Diet, there are certain foods you can avoid to minimize your chances of negative ...

Bio-Path expects to begin preclinical studies for BP1001-A for weight loss in the fourth quarter ... The company initiated a therapeutic program to develop BP1001-A for treating obesity and ...

Some of the most valuable health advancements in 2024 related to weight loss and metabolic health. New findings about ...

In the pursuit of weight loss, many have encountered the myriad of products promising miraculous results. However, finding a ...

Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

For investors who are after steady, mature companies, beverage companies might be a good place to start. But not all of them ...